Marshak Richard (CIK 1982638) reported 14 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-01). Recent activity: Buy TLSI (561 shares), Buy TLSI (279 shares), Buy TLSI (999 shares), Buy TLSI (930 shares), Buy TLSI (449 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-01 | TriSalus Life Sciences, Inc. (TLSI) | Chief Commercial Officer | Buy | 561 | $2,171 |
| 2026-07-01 | TriSalus Life Sciences, Inc. (TLSI) | Chief Commercial Officer | Buy | 279 | $1,309 |
| 2026-07-01 | TriSalus Life Sciences, Inc. (TLSI) | Chief Commercial Officer | Buy | 999 | $4,256 |
| 2026-07-01 | TriSalus Life Sciences, Inc. (TLSI) | Chief Commercial Officer | Buy | 930 | $3,934 |
| 2026-07-01 | TriSalus Life Sciences, Inc. (TLSI) | Chief Commercial Officer | Buy | 449 | $1,967 |
| 2026-05-19 | TriSalus Life Sciences, Inc. (TLSI) | Chief Commercial Officer | Sell | 543 | $1,450 |
| 2026-03-20 | TriSalus Life Sciences, Inc. (TLSI) | Chief Commercial Officer | Sell | 1,449 | $5,984 |
| 2026-03-20 | TriSalus Life Sciences, Inc. (TLSI) | Chief Commercial Officer | Sell | 1,589 | $6,499 |
| 2026-03-20 | TriSalus Life Sciences, Inc. (TLSI) | Chief Commercial Officer | Sell | 419 | $1,726 |
| 2025-11-25 | TriSalus Life Sciences, Inc. (TLSI) | Chief Commercial Officer | Buy | 60,000 | $0 |
| 2025-05-21 | TriSalus Life Sciences, Inc. (TLSI) | Chief Commercial Officer | Buy | 21,428 | $110,997 |
| 2025-05-21 | TriSalus Life Sciences, Inc. (TLSI) | Chief Commercial Officer | Sell | 6,597 | $34,172 |
| 2025-02-19 | TriSalus Life Sciences, Inc. (TLSI) | Chief Commercial Officer | Buy | 7,644 | $0 |
| 2025-01-29 | TriSalus Life Sciences, Inc. (TLSI) | Chief Commercial Officer | Buy | 12,500 | $0 |
Source: SEC Form 4 filings · as of 2026-07-01